Onset time, endotracheal intubating conditions, and plasma histamine after cisatracurium and vecuronium administration

Anesthesia and Analgesia

Volumn 87, Issue 2, 1998, Pages 434-438

  Doenicke, Alfred W ^a   Czeslick, Elke ^b   Moss, Jonathan ^c,d   Hoernecke, Rainer ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^c UNIVERSITY OF CHICAGO   (United States)

^d UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISATRACURIUM; HISTAMINE; VECURONIUM;

ADULT; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG POTENCY; ENDOTRACHEAL INTUBATION; FEMALE; HEMODYNAMICS; HISTAMINE BLOOD LEVEL; HISTAMINE RELEASE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; NEUROMUSCULAR BLOCKING; PRIORITY JOURNAL;

ADULT; AGED; ANESTHESIA, GENERAL; ATRACURIUM; DOUBLE-BLIND METHOD; FEMALE; HISTAMINE; HUMANS; INTUBATION, INTRATRACHEAL; MALE; MIDDLE AGED; NEUROMUSCULAR BLOCKING AGENTS; NEUROMUSCULAR NONDEPOLARIZING AGENTS; PROSPECTIVE STUDIES; TIME FACTORS; VECURONIUM BROMIDE;

EID: 0031848152     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199808000-00038     Document Type: Article

References (20)

1. Belmont MR, Lien CA, Quessy S, et al. The clinical neuromuscular pharmacology of 51W89 in patients receiving nitrous oxide/opioid/barbiturate anesthesia. Anesthesiology 1995;82: 1139-45.
2. 2-opioid anesthesia. Anesth Analg 1996;83:823-9.
3. Lepage JY, Malinovsky JM, Maligne M, et al. Comparison of equipotent doses of 51W89 and atracurium [abstract]. Anesthesiology 1994;81:A1090
4. Mellinghoff H, Radbruch L, Diefenbach C, Buzello W. A comparison of cisatracurium and atracurium: onset of neuromuscular block after bolus injection and recovery after subsequent infusion. Anesth Analg 1996;83:1072-5.
5. 2/propofol anesthesia [abstract]. Anesthesiology 1994; 81:A1081
6. Doenicke A, Soukup J, Hoernecke R, Moss J. The lack of histamine release with cisatracurium: a double blind comparison with vecuronium. Anesth Analg 1997;84:623-8.
7. Lien CA, Belmont MR, Abalos A, et al. The cardiovascular effects and histamine-releasing properties of 51W89 in patients receiving nitrous oxide/opioid/barbiturate anesthesia. Anesthesiology 1995;82:1131-8.
8. Savarese JJ, Viby-Mogensen J, Reich D, Van Aken H. The haemodynamic profile of cisatracurium. Curr Opin Anaesthesiol 1996;9(Suppl 1):36-41.
9. Clendenen SR, Harper JV, Wharen RE, Guarderas JC. Anaphylactic reaction after cisatracurium. Anesthesiology 1997;87: 690-2.
10. Doenicke A, Moss J, Lorenz W, Gottardis M. Are hypotension and rash after atracurium caused by histamine release? Anesth Analg 1994;78:967-72.
11. Goldberg ME, Larijani GE, Azad SS, et al. Comparison of tracheal intubating conditions and neuromuscular blocking profiles after intubating doses of mivacurium chloride or succinylcholine in surgical outpatients. Anesth Analg 1989;69:93-9.
12. Doenicke A, Moss J, Lorenz W, Hoernecke R. Intravenous morphine and nalbuphine increase histamine and catecholamine release without accompanying hemodynamic changes. Clin Pharmacol Ther 1995;58:81-9.
13. McBride P, Bradley D, Kaliner M. Evaluation of a radioimmunoassay for histamine measurement in biologic fluids. J Allergy Clin Immunol 1988;82:638-46.
14. Littlejohn IH, Abhay K, El Sayed A, et al. Intubating conditions following IR CIS, 1'R CIS atracurium (51W89): a comparison with atracurium. Anaesthesia 1995;50:499-502.
15. Pavlin EG, Duvaldestin P, Belmont MR, Flynn RJ. The use of cisatracurium for tracheal intubation. Curr Opin Anaesthesiol 1996;9:23-6.
16. Viby-Mogensen J, Engbaek J, Eriksson LI, et al. Good clinical research practice (GCRP) in pharmacodynamic studies of neuromuscular blocking agents. Acta Anaesthesiol Scan 1996;40: 59-74.
17. Moss J, Rosow CE, Savarese JJ, et al. Role of histamine in the hypotensive action of d-tubocurarine in man. Anesthesiology 1981;55:19-25.
18. Doenicke A, Moss J, Lorenz W, et al. Effect of oral antihistamine premedication on mivacurium-induced histamine release and side effects. Br J Anaesth 1996;77:421-3.
19. Hirschman CA, Edelstein RA, Ebertz JM, Hanifin JM. Thiobarbiturate-induced histamine release in human skin mast cells. Anesthesiology 1985;63:353-6.
20. Lorenz W, Doenicke A, Meyer R, et al. Histamine release in man by propanidid and thiopentone: pharmacological effects and clinical consequences. Br J Anaesth 1972;44:355-69.